Back to comparisons

Comparison

Phosphatidylserine (PS) vs Omega-3 (DHA/EPA)

FieldPhosphatidylserine (PS)Omega-3 (DHA/EPA)
Categorycholinergicneuroprotective
Dose range100–300mg1000–3000mg
Half-life12h24h
Onset
EvidenceEVIDENCEBEVIDENCEA
Safety●●●●●●●●●●
Legal (US)USOTCUSOTC
PubMed refs2805200

The comparison in plain English

Auto-generated from data

Phosphatidylserine (PS) and Omega-3 (DHA/EPA) are both in the cholinergic (cholinergic) and neuroprotective respectively. Phosphatidylserine (PS) Phospholipid concentrated in brain cell membranes. Omega-3 (DHA/EPA) Essential fatty acids critical for brain structure and function.

Bottom line

Phosphatidylserine (PS) (evidence B, safety 5/5) has a stronger evidence base than Omega-3 (DHA/EPA) (evidence A, safety 5/5). Phosphatidylserine (PS) has the slightly cleaner safety profile. For users new to either, the higher-evidence option is the safer first try.

Choose Phosphatidylserine (PS) if

Phosphatidylserine (PS) is the better fit when your goal aligns with its mechanism (A structural phospholipid that comprises 10-20% of neuronal cell membranes, particularly concentrated in the inner leaflet where it supports receptor function and membrane fluidity) and the dose range (100–300mg) suits your protocol. Half-life is 12h.

Choose Omega-3 (DHA/EPA) if

Omega-3 (DHA/EPA) is the better fit when your goal aligns with its mechanism (DHA (docosahexaenoic acid) is a structural component of neuronal cell membranes, maintaining fluidity and supporting receptor function) and the dose range (1000–3000mg) suits your protocol. Half-life is 24h.

Build a stack with bothOpen builder →
Check interactionsOpen checker →